Global Mhealth Market

Mhealth Comprehensive Study by Type (Connected Devices, Apps, Services), Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Diseases, Others), End User (Physicians, Patients, Insurance Companies, Research Centers, Pharmacies, Biopharmaceutical Companies, Government, Tech Companies) Players and Region - Global Market Outlook to 2032

Mhealth Market by XX Submarkets | Forecast Years 2025-2032 | CAGR: 25.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Mhealth
mHealth being one of the eHealth aspects is getting advanced in acquiring, transporting, storing, processing and securing raw & processed data to deliver meaningful results. The rapid rise in the incidence of the chronic diseases as well as the advancing technologies in the mobile health apps has delivered information of personal healthcare on the regular basis which is one of the major factor fuelling the mHealth market. Mobile Health (mHealth) is a general term used for mobile health, which provides assistance to public health using smart devices such as; mobile phones, tablet computers & PDAs, and wearable devices such as smartwatches. It helps in educating consumers about preventive health care services.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)
CAGR25.4%


Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Mhealth market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Omron Corporation (United States), Apple, Inc. (United States), AirStrip Technologies (United States), AliveCor, Inc. (United States), BioTelemetry Inc. (United States), athenahealth, Inc. (United States), AgaMatrix, Inc. (United States), iHealth Lab, Inc. (United States), AT&T (United States), Cerner Corporation (United States), Cisco Systems, Inc. (United States), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), LifeWatch AG (Switzerland), Nokia Corporation (Finland) and Johnson & Johnson (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Diversinet Corporation (Canada) and Withings (France).

Segmentation Overview
AMA Research has segmented the market of Global Mhealth market by Type (Connected Devices, Apps and Services), Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Diseases and Others) and Region.



On the basis of geography, the market of Mhealth has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2024. If we see Market by End User, the sub-segment i.e. Physicians will boost the Mhealth market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advancement in Technology of Connected Devices and mHealth App with Rise in use of Wearable Health Technology, Growing Application of Cloud-Based mHealth Solution and Remote monitoring and Growing Focus on Consumer- Centric Mobility Solutions

Market Growth Drivers:
Rising Use of Mobile phones, Tablets, Smart Phones and other Mobile Platform, Cost Containment of Healthcare Delivery, Rising Focus on Patient-Centric Healthcare Delivery and Increasing Consumption of Connected Devices and mHealth Apps for the Management of Chronic Diseases

Challenges:
Difficulties in Finding mHealth Apps in Stores and Patent Protection for mHealth Devices and Applications

Restraints:
Lack of Standards and Regulations, Increasing Concerns Regarding Health care Fraud And Data Theft which Require Data Security and Lack of guidance from Physicians while Selecting Apps

Opportunities:
Rising Incidence of Lifestyle Disorders and Growing Adoption of mHealth Solutions

Market Leaders and their expansionary development strategies
In June 2017, Johnson & Johnson an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company acquired the Actelion
In September , 2021 - Mount Sinai Health System has introduced a new mHealth app to improve patient data access, enhance patient-provider communication, and create a centralized platform for all patient healthcare needs.
According to the United Nation Department of Economic and Social Affairs (UNDESA), world population ageing 2017 report, in North America, the population of people aged 60 years or above was approximately 78.4 million in 2017, and the number is estimated to reach 122.8 billion by 2050.

Key Target Audience
Healthcare Application Developers, Medical Device Vendors, Mobile Network Providers, Connectivity Providers, Mobile Platform Developers, Insurance Providers (Payers), Healthcare Institutions (Hospitals, Medical Schools, And Outpatient Clinics), Research And Consulting Firms, Research Institutes, Contract Research Organizations (Cros), Contract Manufacturing Organizations (Cmos) and Venture Capitalists

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Connected Devices
  • Apps
  • Services
By Application
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Neurological Diseases
  • Others
By End User
  • Physicians
  • Patients
  • Insurance Companies
  • Research Centers
  • Pharmacies
  • Biopharmaceutical Companies
  • Government
  • Tech Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Use of Mobile phones, Tablets, Smart Phones and other Mobile Platform
      • 3.2.2. Cost Containment of Healthcare Delivery
      • 3.2.3. Rising Focus on Patient-Centric Healthcare Delivery
      • 3.2.4. Increasing Consumption of Connected Devices and mHealth Apps for the Management of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Difficulties in Finding mHealth Apps in Stores
      • 3.3.2. Patent Protection for mHealth Devices and Applications
    • 3.4. Market Trends
      • 3.4.1. Advancement in Technology of Connected Devices and mHealth App with Rise in use of Wearable Health Technology
      • 3.4.2. Growing Application of Cloud-Based mHealth Solution
      • 3.4.3. Remote monitoring and Growing Focus on Consumer- Centric Mobility Solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Mhealth, by Type, Application, End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Mhealth (Value)
      • 5.2.1. Global Mhealth by: Type (Value)
        • 5.2.1.1. Connected Devices
        • 5.2.1.2. Apps
        • 5.2.1.3. Services
      • 5.2.2. Global Mhealth by: Application (Value)
        • 5.2.2.1. Cardiovascular Diseases
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Respiratory Diseases
        • 5.2.2.4. Neurological Diseases
        • 5.2.2.5. Others
      • 5.2.3. Global Mhealth by: End User (Value)
        • 5.2.3.1. Physicians
        • 5.2.3.2. Patients
        • 5.2.3.3. Insurance Companies
        • 5.2.3.4. Research Centers
        • 5.2.3.5. Pharmacies
        • 5.2.3.6. Biopharmaceutical Companies
        • 5.2.3.7. Government
        • 5.2.3.8. Tech Companies
      • 5.2.4. Global Mhealth Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Mhealth: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Omron Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Apple, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AirStrip Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AliveCor, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioTelemetry Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Athenahealth, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AgaMatrix, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IHealth Lab, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AT&T (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cerner Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cisco Systems, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Medtronic plc (Ireland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Koninklijke Philips N.V. (Netherlands)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. LifeWatch AG (Switzerland)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Nokia Corporation (Finland)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Johnson & Johnson (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Mhealth Sale, by Type, Application, End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Mhealth (Value)
      • 7.2.1. Global Mhealth by: Type (Value)
        • 7.2.1.1. Connected Devices
        • 7.2.1.2. Apps
        • 7.2.1.3. Services
      • 7.2.2. Global Mhealth by: Application (Value)
        • 7.2.2.1. Cardiovascular Diseases
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Respiratory Diseases
        • 7.2.2.4. Neurological Diseases
        • 7.2.2.5. Others
      • 7.2.3. Global Mhealth by: End User (Value)
        • 7.2.3.1. Physicians
        • 7.2.3.2. Patients
        • 7.2.3.3. Insurance Companies
        • 7.2.3.4. Research Centers
        • 7.2.3.5. Pharmacies
        • 7.2.3.6. Biopharmaceutical Companies
        • 7.2.3.7. Government
        • 7.2.3.8. Tech Companies
      • 7.2.4. Global Mhealth Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Mhealth: by Type(USD Million)
  • Table 2. Mhealth Connected Devices , by Region USD Million (2019-2024)
  • Table 3. Mhealth Apps , by Region USD Million (2019-2024)
  • Table 4. Mhealth Services , by Region USD Million (2019-2024)
  • Table 5. Mhealth: by Application(USD Million)
  • Table 6. Mhealth Cardiovascular Diseases , by Region USD Million (2019-2024)
  • Table 7. Mhealth Diabetes , by Region USD Million (2019-2024)
  • Table 8. Mhealth Respiratory Diseases , by Region USD Million (2019-2024)
  • Table 9. Mhealth Neurological Diseases , by Region USD Million (2019-2024)
  • Table 10. Mhealth Others , by Region USD Million (2019-2024)
  • Table 11. Mhealth: by End User(USD Million)
  • Table 12. Mhealth Physicians , by Region USD Million (2019-2024)
  • Table 13. Mhealth Patients , by Region USD Million (2019-2024)
  • Table 14. Mhealth Insurance Companies , by Region USD Million (2019-2024)
  • Table 15. Mhealth Research Centers , by Region USD Million (2019-2024)
  • Table 16. Mhealth Pharmacies , by Region USD Million (2019-2024)
  • Table 17. Mhealth Biopharmaceutical Companies , by Region USD Million (2019-2024)
  • Table 18. Mhealth Government , by Region USD Million (2019-2024)
  • Table 19. Mhealth Tech Companies , by Region USD Million (2019-2024)
  • Table 20. South America Mhealth, by Country USD Million (2019-2024)
  • Table 21. South America Mhealth, by Type USD Million (2019-2024)
  • Table 22. South America Mhealth, by Application USD Million (2019-2024)
  • Table 23. South America Mhealth, by End User USD Million (2019-2024)
  • Table 24. Brazil Mhealth, by Type USD Million (2019-2024)
  • Table 25. Brazil Mhealth, by Application USD Million (2019-2024)
  • Table 26. Brazil Mhealth, by End User USD Million (2019-2024)
  • Table 27. Argentina Mhealth, by Type USD Million (2019-2024)
  • Table 28. Argentina Mhealth, by Application USD Million (2019-2024)
  • Table 29. Argentina Mhealth, by End User USD Million (2019-2024)
  • Table 30. Rest of South America Mhealth, by Type USD Million (2019-2024)
  • Table 31. Rest of South America Mhealth, by Application USD Million (2019-2024)
  • Table 32. Rest of South America Mhealth, by End User USD Million (2019-2024)
  • Table 33. Asia Pacific Mhealth, by Country USD Million (2019-2024)
  • Table 34. Asia Pacific Mhealth, by Type USD Million (2019-2024)
  • Table 35. Asia Pacific Mhealth, by Application USD Million (2019-2024)
  • Table 36. Asia Pacific Mhealth, by End User USD Million (2019-2024)
  • Table 37. China Mhealth, by Type USD Million (2019-2024)
  • Table 38. China Mhealth, by Application USD Million (2019-2024)
  • Table 39. China Mhealth, by End User USD Million (2019-2024)
  • Table 40. Japan Mhealth, by Type USD Million (2019-2024)
  • Table 41. Japan Mhealth, by Application USD Million (2019-2024)
  • Table 42. Japan Mhealth, by End User USD Million (2019-2024)
  • Table 43. India Mhealth, by Type USD Million (2019-2024)
  • Table 44. India Mhealth, by Application USD Million (2019-2024)
  • Table 45. India Mhealth, by End User USD Million (2019-2024)
  • Table 46. South Korea Mhealth, by Type USD Million (2019-2024)
  • Table 47. South Korea Mhealth, by Application USD Million (2019-2024)
  • Table 48. South Korea Mhealth, by End User USD Million (2019-2024)
  • Table 49. Taiwan Mhealth, by Type USD Million (2019-2024)
  • Table 50. Taiwan Mhealth, by Application USD Million (2019-2024)
  • Table 51. Taiwan Mhealth, by End User USD Million (2019-2024)
  • Table 52. Australia Mhealth, by Type USD Million (2019-2024)
  • Table 53. Australia Mhealth, by Application USD Million (2019-2024)
  • Table 54. Australia Mhealth, by End User USD Million (2019-2024)
  • Table 55. Rest of Asia-Pacific Mhealth, by Type USD Million (2019-2024)
  • Table 56. Rest of Asia-Pacific Mhealth, by Application USD Million (2019-2024)
  • Table 57. Rest of Asia-Pacific Mhealth, by End User USD Million (2019-2024)
  • Table 58. Europe Mhealth, by Country USD Million (2019-2024)
  • Table 59. Europe Mhealth, by Type USD Million (2019-2024)
  • Table 60. Europe Mhealth, by Application USD Million (2019-2024)
  • Table 61. Europe Mhealth, by End User USD Million (2019-2024)
  • Table 62. Germany Mhealth, by Type USD Million (2019-2024)
  • Table 63. Germany Mhealth, by Application USD Million (2019-2024)
  • Table 64. Germany Mhealth, by End User USD Million (2019-2024)
  • Table 65. France Mhealth, by Type USD Million (2019-2024)
  • Table 66. France Mhealth, by Application USD Million (2019-2024)
  • Table 67. France Mhealth, by End User USD Million (2019-2024)
  • Table 68. Italy Mhealth, by Type USD Million (2019-2024)
  • Table 69. Italy Mhealth, by Application USD Million (2019-2024)
  • Table 70. Italy Mhealth, by End User USD Million (2019-2024)
  • Table 71. United Kingdom Mhealth, by Type USD Million (2019-2024)
  • Table 72. United Kingdom Mhealth, by Application USD Million (2019-2024)
  • Table 73. United Kingdom Mhealth, by End User USD Million (2019-2024)
  • Table 74. Netherlands Mhealth, by Type USD Million (2019-2024)
  • Table 75. Netherlands Mhealth, by Application USD Million (2019-2024)
  • Table 76. Netherlands Mhealth, by End User USD Million (2019-2024)
  • Table 77. Rest of Europe Mhealth, by Type USD Million (2019-2024)
  • Table 78. Rest of Europe Mhealth, by Application USD Million (2019-2024)
  • Table 79. Rest of Europe Mhealth, by End User USD Million (2019-2024)
  • Table 80. MEA Mhealth, by Country USD Million (2019-2024)
  • Table 81. MEA Mhealth, by Type USD Million (2019-2024)
  • Table 82. MEA Mhealth, by Application USD Million (2019-2024)
  • Table 83. MEA Mhealth, by End User USD Million (2019-2024)
  • Table 84. Middle East Mhealth, by Type USD Million (2019-2024)
  • Table 85. Middle East Mhealth, by Application USD Million (2019-2024)
  • Table 86. Middle East Mhealth, by End User USD Million (2019-2024)
  • Table 87. Africa Mhealth, by Type USD Million (2019-2024)
  • Table 88. Africa Mhealth, by Application USD Million (2019-2024)
  • Table 89. Africa Mhealth, by End User USD Million (2019-2024)
  • Table 90. North America Mhealth, by Country USD Million (2019-2024)
  • Table 91. North America Mhealth, by Type USD Million (2019-2024)
  • Table 92. North America Mhealth, by Application USD Million (2019-2024)
  • Table 93. North America Mhealth, by End User USD Million (2019-2024)
  • Table 94. United States Mhealth, by Type USD Million (2019-2024)
  • Table 95. United States Mhealth, by Application USD Million (2019-2024)
  • Table 96. United States Mhealth, by End User USD Million (2019-2024)
  • Table 97. Canada Mhealth, by Type USD Million (2019-2024)
  • Table 98. Canada Mhealth, by Application USD Million (2019-2024)
  • Table 99. Canada Mhealth, by End User USD Million (2019-2024)
  • Table 100. Mexico Mhealth, by Type USD Million (2019-2024)
  • Table 101. Mexico Mhealth, by Application USD Million (2019-2024)
  • Table 102. Mexico Mhealth, by End User USD Million (2019-2024)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Mhealth: by Type(USD Million)
  • Table 120. Mhealth Connected Devices , by Region USD Million (2027-2032)
  • Table 121. Mhealth Apps , by Region USD Million (2027-2032)
  • Table 122. Mhealth Services , by Region USD Million (2027-2032)
  • Table 123. Mhealth: by Application(USD Million)
  • Table 124. Mhealth Cardiovascular Diseases , by Region USD Million (2027-2032)
  • Table 125. Mhealth Diabetes , by Region USD Million (2027-2032)
  • Table 126. Mhealth Respiratory Diseases , by Region USD Million (2027-2032)
  • Table 127. Mhealth Neurological Diseases , by Region USD Million (2027-2032)
  • Table 128. Mhealth Others , by Region USD Million (2027-2032)
  • Table 129. Mhealth: by End User(USD Million)
  • Table 130. Mhealth Physicians , by Region USD Million (2027-2032)
  • Table 131. Mhealth Patients , by Region USD Million (2027-2032)
  • Table 132. Mhealth Insurance Companies , by Region USD Million (2027-2032)
  • Table 133. Mhealth Research Centers , by Region USD Million (2027-2032)
  • Table 134. Mhealth Pharmacies , by Region USD Million (2027-2032)
  • Table 135. Mhealth Biopharmaceutical Companies , by Region USD Million (2027-2032)
  • Table 136. Mhealth Government , by Region USD Million (2027-2032)
  • Table 137. Mhealth Tech Companies , by Region USD Million (2027-2032)
  • Table 138. South America Mhealth, by Country USD Million (2027-2032)
  • Table 139. South America Mhealth, by Type USD Million (2027-2032)
  • Table 140. South America Mhealth, by Application USD Million (2027-2032)
  • Table 141. South America Mhealth, by End User USD Million (2027-2032)
  • Table 142. Brazil Mhealth, by Type USD Million (2027-2032)
  • Table 143. Brazil Mhealth, by Application USD Million (2027-2032)
  • Table 144. Brazil Mhealth, by End User USD Million (2027-2032)
  • Table 145. Argentina Mhealth, by Type USD Million (2027-2032)
  • Table 146. Argentina Mhealth, by Application USD Million (2027-2032)
  • Table 147. Argentina Mhealth, by End User USD Million (2027-2032)
  • Table 148. Rest of South America Mhealth, by Type USD Million (2027-2032)
  • Table 149. Rest of South America Mhealth, by Application USD Million (2027-2032)
  • Table 150. Rest of South America Mhealth, by End User USD Million (2027-2032)
  • Table 151. Asia Pacific Mhealth, by Country USD Million (2027-2032)
  • Table 152. Asia Pacific Mhealth, by Type USD Million (2027-2032)
  • Table 153. Asia Pacific Mhealth, by Application USD Million (2027-2032)
  • Table 154. Asia Pacific Mhealth, by End User USD Million (2027-2032)
  • Table 155. China Mhealth, by Type USD Million (2027-2032)
  • Table 156. China Mhealth, by Application USD Million (2027-2032)
  • Table 157. China Mhealth, by End User USD Million (2027-2032)
  • Table 158. Japan Mhealth, by Type USD Million (2027-2032)
  • Table 159. Japan Mhealth, by Application USD Million (2027-2032)
  • Table 160. Japan Mhealth, by End User USD Million (2027-2032)
  • Table 161. India Mhealth, by Type USD Million (2027-2032)
  • Table 162. India Mhealth, by Application USD Million (2027-2032)
  • Table 163. India Mhealth, by End User USD Million (2027-2032)
  • Table 164. South Korea Mhealth, by Type USD Million (2027-2032)
  • Table 165. South Korea Mhealth, by Application USD Million (2027-2032)
  • Table 166. South Korea Mhealth, by End User USD Million (2027-2032)
  • Table 167. Taiwan Mhealth, by Type USD Million (2027-2032)
  • Table 168. Taiwan Mhealth, by Application USD Million (2027-2032)
  • Table 169. Taiwan Mhealth, by End User USD Million (2027-2032)
  • Table 170. Australia Mhealth, by Type USD Million (2027-2032)
  • Table 171. Australia Mhealth, by Application USD Million (2027-2032)
  • Table 172. Australia Mhealth, by End User USD Million (2027-2032)
  • Table 173. Rest of Asia-Pacific Mhealth, by Type USD Million (2027-2032)
  • Table 174. Rest of Asia-Pacific Mhealth, by Application USD Million (2027-2032)
  • Table 175. Rest of Asia-Pacific Mhealth, by End User USD Million (2027-2032)
  • Table 176. Europe Mhealth, by Country USD Million (2027-2032)
  • Table 177. Europe Mhealth, by Type USD Million (2027-2032)
  • Table 178. Europe Mhealth, by Application USD Million (2027-2032)
  • Table 179. Europe Mhealth, by End User USD Million (2027-2032)
  • Table 180. Germany Mhealth, by Type USD Million (2027-2032)
  • Table 181. Germany Mhealth, by Application USD Million (2027-2032)
  • Table 182. Germany Mhealth, by End User USD Million (2027-2032)
  • Table 183. France Mhealth, by Type USD Million (2027-2032)
  • Table 184. France Mhealth, by Application USD Million (2027-2032)
  • Table 185. France Mhealth, by End User USD Million (2027-2032)
  • Table 186. Italy Mhealth, by Type USD Million (2027-2032)
  • Table 187. Italy Mhealth, by Application USD Million (2027-2032)
  • Table 188. Italy Mhealth, by End User USD Million (2027-2032)
  • Table 189. United Kingdom Mhealth, by Type USD Million (2027-2032)
  • Table 190. United Kingdom Mhealth, by Application USD Million (2027-2032)
  • Table 191. United Kingdom Mhealth, by End User USD Million (2027-2032)
  • Table 192. Netherlands Mhealth, by Type USD Million (2027-2032)
  • Table 193. Netherlands Mhealth, by Application USD Million (2027-2032)
  • Table 194. Netherlands Mhealth, by End User USD Million (2027-2032)
  • Table 195. Rest of Europe Mhealth, by Type USD Million (2027-2032)
  • Table 196. Rest of Europe Mhealth, by Application USD Million (2027-2032)
  • Table 197. Rest of Europe Mhealth, by End User USD Million (2027-2032)
  • Table 198. MEA Mhealth, by Country USD Million (2027-2032)
  • Table 199. MEA Mhealth, by Type USD Million (2027-2032)
  • Table 200. MEA Mhealth, by Application USD Million (2027-2032)
  • Table 201. MEA Mhealth, by End User USD Million (2027-2032)
  • Table 202. Middle East Mhealth, by Type USD Million (2027-2032)
  • Table 203. Middle East Mhealth, by Application USD Million (2027-2032)
  • Table 204. Middle East Mhealth, by End User USD Million (2027-2032)
  • Table 205. Africa Mhealth, by Type USD Million (2027-2032)
  • Table 206. Africa Mhealth, by Application USD Million (2027-2032)
  • Table 207. Africa Mhealth, by End User USD Million (2027-2032)
  • Table 208. North America Mhealth, by Country USD Million (2027-2032)
  • Table 209. North America Mhealth, by Type USD Million (2027-2032)
  • Table 210. North America Mhealth, by Application USD Million (2027-2032)
  • Table 211. North America Mhealth, by End User USD Million (2027-2032)
  • Table 212. United States Mhealth, by Type USD Million (2027-2032)
  • Table 213. United States Mhealth, by Application USD Million (2027-2032)
  • Table 214. United States Mhealth, by End User USD Million (2027-2032)
  • Table 215. Canada Mhealth, by Type USD Million (2027-2032)
  • Table 216. Canada Mhealth, by Application USD Million (2027-2032)
  • Table 217. Canada Mhealth, by End User USD Million (2027-2032)
  • Table 218. Mexico Mhealth, by Type USD Million (2027-2032)
  • Table 219. Mexico Mhealth, by Application USD Million (2027-2032)
  • Table 220. Mexico Mhealth, by End User USD Million (2027-2032)
  • Table 221. Research Programs/Design for This Report
  • Table 222. Key Data Information from Secondary Sources
  • Table 223. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Mhealth: by Type USD Million (2019-2024)
  • Figure 5. Global Mhealth: by Application USD Million (2019-2024)
  • Figure 6. Global Mhealth: by End User USD Million (2019-2024)
  • Figure 7. South America Mhealth Share (%), by Country
  • Figure 8. Asia Pacific Mhealth Share (%), by Country
  • Figure 9. Europe Mhealth Share (%), by Country
  • Figure 10. MEA Mhealth Share (%), by Country
  • Figure 11. North America Mhealth Share (%), by Country
  • Figure 12. Global Mhealth share by Players 2024 (%)
  • Figure 13. Global Mhealth share by Players (Top 3) 2024(%)
  • Figure 14. Global Mhealth share by Players (Top 5) 2024(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Omron Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Omron Corporation (United States) Revenue: by Geography 2024
  • Figure 18. Apple, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Apple, Inc. (United States) Revenue: by Geography 2024
  • Figure 20. AirStrip Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 21. AirStrip Technologies (United States) Revenue: by Geography 2024
  • Figure 22. AliveCor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. AliveCor, Inc. (United States) Revenue: by Geography 2024
  • Figure 24. BioTelemetry Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. BioTelemetry Inc. (United States) Revenue: by Geography 2024
  • Figure 26. Athenahealth, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Athenahealth, Inc. (United States) Revenue: by Geography 2024
  • Figure 28. AgaMatrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. AgaMatrix, Inc. (United States) Revenue: by Geography 2024
  • Figure 30. IHealth Lab, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. IHealth Lab, Inc. (United States) Revenue: by Geography 2024
  • Figure 32. AT&T (United States) Revenue, Net Income and Gross profit
  • Figure 33. AT&T (United States) Revenue: by Geography 2024
  • Figure 34. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Cerner Corporation (United States) Revenue: by Geography 2024
  • Figure 36. Cisco Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Cisco Systems, Inc. (United States) Revenue: by Geography 2024
  • Figure 38. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 39. Medtronic plc (Ireland) Revenue: by Geography 2024
  • Figure 40. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 41. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2024
  • Figure 42. LifeWatch AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 43. LifeWatch AG (Switzerland) Revenue: by Geography 2024
  • Figure 44. Nokia Corporation (Finland) Revenue, Net Income and Gross profit
  • Figure 45. Nokia Corporation (Finland) Revenue: by Geography 2024
  • Figure 46. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 47. Johnson & Johnson (United States) Revenue: by Geography 2024
  • Figure 48. Global Mhealth: by Type USD Million (2027-2032)
  • Figure 49. Global Mhealth: by Application USD Million (2027-2032)
  • Figure 50. Global Mhealth: by End User USD Million (2027-2032)
  • Figure 51. South America Mhealth Share (%), by Country
  • Figure 52. Asia Pacific Mhealth Share (%), by Country
  • Figure 53. Europe Mhealth Share (%), by Country
  • Figure 54. MEA Mhealth Share (%), by Country
  • Figure 55. North America Mhealth Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Omron Corporation (United States)
  • Apple, Inc. (United States)
  • AirStrip Technologies (United States)
  • AliveCor, Inc. (United States)
  • BioTelemetry Inc. (United States)
  • athenahealth, Inc. (United States)
  • AgaMatrix, Inc. (United States)
  • iHealth Lab, Inc. (United States)
  • AT&T (United States)
  • Cerner Corporation (United States)
  • Cisco Systems, Inc. (United States)
  • Medtronic plc (Ireland)
  • Koninklijke Philips N.V. (Netherlands)
  • LifeWatch AG (Switzerland)
  • Nokia Corporation (Finland)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Diversinet Corporation (Canada) , Withings (France)
Select User Access Type

Key Highlights of Report


Nov 2024 207 Pages 56 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Mhealth Market Quantitative research analysis
Global Mhealth Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Omron Corporation (United States), Apple, Inc. (United States), AirStrip Technologies (United States), AliveCor, Inc. (United States), BioTelemetry Inc. (United States), athenahealth, Inc. (United States), AgaMatrix, Inc. (United States), iHealth Lab, Inc. (United States), AT&T (United States), Cerner Corporation (United States), Cisco Systems, Inc. (United States), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), LifeWatch AG (Switzerland), Nokia Corporation (Finland) and Johnson & Johnson (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advancement in Technology of Connected Devices and mHealth App with Rise in use of Wearable Health Technology " is seen as one of major influencing trends for Mhealth Market during projected period 2024-2032.
The Mhealth market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Mhealth Market to reach USD151.48 Million by 2032.

Know More About Global Mhealth Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare API Comprehensive Study by Type (Appointments and Payment, Medical Device (Wearable), Electronic Health Record Access, Remote Patient Monitoring), Application (Medical Device Integration, ...
$ 3750
Veterinary Surgical Equipments Comprehensive Study by Type (Sutures, Staplers and Accessories, Handheld Devices {Forceps, Scalpels, Surgical Scissors, Hooks & Retractors, Trocars & Cannulas}, Electro...
$ 3750
Emergency Department Information System Comprehensive Study by Type (Software, Services, Hardware), Application (Clinical Functionality, Patient Entry, Tracking and Triage, Department-Centered Tracki...
$ 3750
Radiation Dose Monitoring Comprehensive Study by Type (Dosimeters, Area Process Monitors, Others), Application (Oncology, Cardiology, Orthopedic Applications, Others), Component (Software, Service), ...
$ 3750
Blue Biotechnology Comprehensive Study by Type (Pharmaceutical, Bio-Fuels, Food, Enzymes, Bio-Polymers, Others), Application (Vaccine development, Drug finding, Genomics, Others), End Users (Hospital...
$ 3650
Hybrid Operating Room Comprehensive Study by Application (Cardiovascular applications, Neurosurgical applications, Thoracic applications, Orthopedic applications, Other), Technology (Fluoroscopy & Da...
$ 3750